Hjem › Polymyositis › New York
Polymyositis kliniske forsøg i New York
3 studier for Polymyositis søger deltagere på steder i New York.
Officiel studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Great Neck
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 24. sep. 2026 · NCT06455449A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NYU Langone Health - Clinical and Translational Science Institute Research Pharmacy, New York
- NYU Langone Health Clinical Research Center, New York
- NYU Langone Health, New York
- og 3 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05895786Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. jul. 2026 · NCT07138898Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.